Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Noninvasive Occlusion Spectroscopy Assessed for Blood Banks

By LabMedica International staff writers
Posted on 05 Jun 2013
The feasibility of using noninvasive occlusion spectroscopy method in a blood bank to determine hemoglobin (Hb) levels has been compared with standard methods.

The tests used for anemia screening in blood donors are based on phlebotomy samples, leading to discomfort and complaint, which can be avoided by using occlusion spectroscopy that makes the procedure more comfortable and could therefore contribute to greater donor retention.

Hematologists at the University of Campinas (Brazil) enrolled 205 consecutive volunteer blood donors of whom, 136 were males and 69 females with an age range of 18 to 65 years, with the median at 32 years. Samples were collected by fingerstick and venous puncture to determine Hb level by a photometer (Hb-F) and automatic blood analyzer (Hb-V) and compared to the noninvasive Hb (Hb-NI) determination by occlusion spectroscopy (Orsense Ltd.; Nes Ziona, Israel).

The Hb-NI determination was performed by pressure applied by a ring-shaped multiwave length sensor probe containing a pneumatic cuff that temporarily occludes the blood flow in the base of the finger and generates a strong optical signal, yielding a high signal-to-noise ratio that is wholly blood specific. Analysis of the signal in the wavelength range of 600 to 1,500 nm provides the necessary sensitivity for measuring Hb concentration and pulse rate. The test is performed in 90 seconds, and is far more comfortable for the donors than phlebotomy.

The results obtained with Hb-F using the Hemocue Hb201+ (Ängelholm, Sweden) showed significant above value differences in the general group as well as when stratified by sex, weight, and age groups, than those obtained with Hb-V using the CellDyn Ruby automatic analyzer (Abbott Laboratories, Abbott Park, IL, USA ). There were significant differences between Hb-NI that were below Hb-V values when measured using the NBM200 occlusion spectroscopy method, but only in females and weight levels between 61 kg to 70 kg.

The authors concluded that the Hb-NI is a feasible and noninvasive to screen donors. It is safe, easy to perform, and quick and does not require extremely specialized technicians. It may also be used in mobile units due to its portability and may be used with power supply or batteries, which allows approximately 100 tests per battery. An issue that should be considered is the higher cost per test of Hb-NI, about USD 1.13 compared to the Hb-F at around USD 0.50. The study was published in the April 2013 edition of the journal Transfusion.

Related Links:

University of Campinas
Orsense Ltd.
Hemocue
Abbott Laboratories


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Immunofluorescence Analyzer
MPQuanti
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.